Nick Myerberg, Partner & Head of AI at Braidwell on AI's Next Era in Drug Discovery
Synopsis: The guest on today's podcast is a representative of Braidwell LP, a registered investment adviser. Braidwell invests on behalf of its clients and either holds, or may in the future hold, p...
3 Elo 47min
Robert Jacks, CEO of Sparrow Pharmaceuticals | Precision Medicine, Biotech Strategy & Leadership
Synopsis: In an industry often defined by rapid innovation and high-stakes science, long-term success in biotech requires more than breakthrough discoveries—it demands strategic clarity, resilient l...
22 Heinä 34min
Ardelyx Leaders Mike Raab & Laura Williams on Building Biotech Around Patients
Synopsis: While biotech is increasingly measured by clinical milestones and financial outcomes, Rahul Chaturvedi welcomes two leaders who argue that true success begins and ends with patients. In th...
10 Kesä 41min
Acadia CEO Catherine Owen Adams on Neurodegeneration, AI & Building Biotech Vision
Synopsis: At the intersection of personal mission and biotech leadership, Rahul Chaturvedi sits down with Catherine Owen Adams, CEO of Acadia Pharmaceuticals, for a deeply personal and strategically...
13 Touko 33min
Barry Quart, CEO of Connect Biopharma, on Asthma Innovation & Biotech Leadership
Synopsis: This episode is proudly sponsored by Quartzy. At a time when biotech innovation is being reshaped by science, capital, and global dynamics, Alok Tayi sits down with Barry Quart, CEO of Co...
16 Huhti 23min
Adial CEO Cary Claiborne on Treating Alcohol Addiction with Genetics
Synopsis: Addiction is often misunderstood as a failure of willpower—but emerging science increasingly shows it may be deeply rooted in biology. In this episode of Biotech 2050, recorded during JPM...
6 Maalis 14min
Sheila Gujrathi, MD on Leadership, Biotech Innovation & The Mirror Effect for Women Leaders
Synopsis: This episode is proudly sponsored by Quartzy. Physician-scientist, biotech founder, and leadership advocate Sheila Gujrathi, MD joins Rahul Chaturvedi on the Biotech 2050 Podcast for a po...
5 Maalis 39min
Fred Aslan, Artiva CEO, on Cell Therapy’s Next Wave, RA Trials & Scalable NK Platforms
Synopsis: At the heart of JPM 2026’s biotech buzz, Alok Tayi sits down with Fred Aslan, CEO of Artiva, to explore how bold platform bets, scalable cell therapies, and autoimmune breakthroughs could ...
11 Helmi 25min
